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Fibronectin production by human tubular cells: The effect of apical
protein. In progressive renal disease the degree of renal failure correlates
with interstitial scarring and the rate of progression correlates with the
degree of proteinuria. This has led to the hypothesis that proteinuria may
cause interstitial scarring. Human tubular cells (HTC) grown on perme-
able membrane supports were characterized to be predominantly of
proximal tubular origin. HTC produce the matrix protein fibronectin in a
polarised fashion the ratio of basolateral to apical secretion being 2.9
0.2 at 48 hours. The addition of serum proteins (1.0 mg/mI) to the apical
medium resulted in increased basolateral secretion of fibronectin, 2.62
0.23-fold after 24 hours and 2.40 0.16-fold after 48 hours. Serum
fractionation revealed that the stimulant to fibronectin production had a
molecular weight 40 to 100 kDa. Platelet derived growth factor secretion
was also stimulated by apical exposure to serum but transforming growth
factor f3 secretion was not detected. Addition of neutralizing anti-PDGF
antibodies did not decrease fibronectin secretion. The activity of serum
was not reproduced by albumin or by transferrin. Exposure of HTC to
serum resulted in increased release of lactate dehydrogenase, suggesting a
degree of cytotoxicity. This evidence could provide a mechanism for the
link between proteinuria and interstitial scarring.
The cause of progression of chronic renal failure is unknown
and it is likely to be multifactorial [1]. In recent years increased
attention has been paid to the role of the tubulointerstitium in this
process. The characteristic histology of the kidney as it ap-
proaches end-stage renal failure is one of tubular atrophy, inter-
stitial scarring and an interstitial chronic inflammatory cell infil-
trate [2, 3]. It has been shown that the degree of interstitial change
is the best histological correlate with renal function [4, 5]. It is not
clear, however, why interstitial disease should occur in conditions
considered to be primarily of glomerular origin. It is likely to be
the result of an alteration in the environment of the tubulointer-
stitium secondary to the glomerular disease. One such change in
the tubular milieu results from the development of proteinuria. As
a result of proteinuria the luminal surface of the tubular cells is
exposed to large amounts of medium and high molecular weight
proteins from which they are normally protected by the glomer-
ular barrier. Such abnormal exposure to proteins could stimulate
the tubular cells to initiate the inflammatory and scarring re-
sponse. The proximal tubular cell would be especially vulnerable
since it has a physiological role to reabsorb proteins from the
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glomerular ultrafiltrate [6]. This hypothesis would provide an
explanation for the known correlation between the degree of
proteinuria and the subsequent rate of progression of renal failure
[7—10].
A possible mechanism by which tubular cells could influence
interstitial scarring is through the production of extracellular
matrix proteins or profibrotic cytokines. The origin of the matrix
proteins that accumulate in interstitial scarring have not been
defined, but the observation that tubular cells in culture can
manufacture interstitial collagens provides evidence that they
could contribute to this process [11]. This study investigated
whether or not human tubular cells in culture can manufacture
the matrix protein fibronectin, and whether or not fibronectin
production is stimulated by exposure of their apical surface to
serum proteins.
Methods
Materials
Cell culture media were obtained from Life Technologies, UK.
Defined medium additives, collagen and fibronectin antibodies
were supplied by Sigma Chemical Company, UK. Antibodies for
cell characterization were from Dako UK. Permeable membrane
supports were purchased from Costar UK. Radiochemicals were
from Amersham UK. Chromatography columns were from Phar-
macia Biotech UK. TGF/3 and PDGF assays were purchased from
R and D Systems UK, as were the anti-PDGF antibodies.
Cell culture
Human tubular cells were isolated by a modification of the
method of Detrisac et al [12]. The outer cortex was dissected from
the normal pole of kidneys removed for treatment of carcinoma or
from donor kidneys deemed unsuitable for transplantation and
cut into 1 mm3 pieces. These were suspended in type II collage-
nase (1.0 mg/mi) at 37°C for 30 minutes. The digest was passed
through a series of sieves of diminishing mesh size and the
glomeruli removed on the top of the 90 j.tm mesh. The tubular
fragments which passed through the sieves were seeded into 75
cm2 flasks which had previously been coated with bovine collagen
type I and adsorbed fetal calf serum proteins.
The cells were grown in DMEM:F12 with the addition of 25 mM
HEPES buffer, insulin (5 rg/ml), transferrin (5 .rg/ml), selenium
(5 ng/ml), tri-iodo-thyronine (4 pg/mi), hydrocortisone (36 ng/ml),
benzyl penicillin (100 lU/mi) and streptomycin (50 j.g/m1). After
10 to 14 days the cells reached confluence. At the second passage
the cells were transferred into six well plates on polycarbonate
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permeable membrane supports of 3.0 tm pore size coated with
collagen type I. They were grown in the medium described above
with the addition of 5% fetal calf serum since it was found that the
serum was required to achieve confluent monolayers on the
membranes. The apical and basolateral media were thus sepa-
rated by the confluent layer of cells and could therefore be
sampled independently.
Permeability studies
To ensure that there was an insignificant leakage of proteins
across the membrane the permeability of the monolayers to
'251-albumin was measured. Following quiescence of the cells 10
d of '251-albumin solution was added to the apical medium of
each well. Apical and basolateral media were sampled at 24 and
48 hours and the activity counted in a gamma counter. Samples
were precipitated with 10% trichloroacetic acid in order to
distinguish between albumin that leaked between the cells and
that which was endocytosed by the cells and metabolized with
release of labeled amino acids into the basolateral medium.
Cell characterization
Morphology of the cells on the permeable supports was exam-
ined by transmission and scanning electron microscopy using
standard techniques. Cytospins of cells from second passage were
prepared for immunostaining. The cells were stained with mouse
monoclonal antibodies to human epithelial membrane antigen,
cytokeratin and factor VIII related antigen and stained for
nonspecific esterase by a standard method [13, 141. Cyclic 3'S'
adenosine monophosphate production by the cells was measured
in response to parathyroid hormone (106 M) and arginine
vasopressin (106 M) in the presence of the phosphodiesterase
inhibitor isobutyi-3-methyl xanthine (5 mM) [15]. cAMP was
measured by radioimmunoassay.
Serum preparation
The serum was collected from normal volunteers. Fibronectin
was removed from the serum using gelatin conjugated agarose
batch affinity chromatography [16]. Briefly, 2 ml of serum was
added to 3 ml of gelatin agarose suspended in Tris-HC1 pH 7.1 in
the presence of 1 ms benzamidine protease inhibitor. After 30
minutes the agarose was removed by centrifugation and the serum
added to a further 3 ml of gelatin agarose for 30 minutes. The
supernatant was removed and nonspecifically bound proteins
were dislodged from the gelatin agarose by washing with 1 M
sodium chloride. The washings and the serum were pooled and
then concentrated using centrifugal concentrators of a molecular
weight cut-off of 3,000 Da. The serum was dialyzed against a
phosphate buffered saline. The fibronectin in medium to which 1.0
mg/mi of serum had been added was reduced from 4.5 0.6
j.g/ml to 0,08 0.01 tig/ml by this method. This represents a 98%
depletion of the fibronectin content of serum. The protein con-
centration of the serum was measured by Bio Rad DC assay prior
to addition to the medium bathing the cells.
Effect of serum proteins on ,fibronectin production
On reaching confluence the medium was changed to DMEM
with addition of 25 mrvi HEPES, hydrocortisone (36 ng/ml), benzyl
penicillin (100 lU/mi) and streptomycin (50 j.g/ml). This medium
contains a physiological concentration of glucose (5.5 mM) since it
has previously been shown that supraphysiological concentrations
of glucose are themselves a stimulus to matrix protein production
by tubular cells [11]. After 24 hours in this medium, to achieve
quiescence, the media bathing both the apical and basolateral
surfaces of the cells was changed such that the apical medium
contained serum proteins at a concentration of 0.1 or 1.0 mg/ml.
An equivalent volume of phosphate buffered saline was added to
the apical medium of the controls. The medium was sampled at 24
and 48 hours and stored at —20°C. Following removal of the
medium at 48 hours 1% nonidet P40 was added to the wells and
the cells scraped off the membrane. They were solubilized by
sonnication. Total cell protein and cell associated fibronectin were
measured in the cell solution.
To determine any effects due to complement in the serum,
experiments were performed in which complement was inacti-
vated by heating the serum to 56°C for 30 minutes in a water bath
prior to addition to the culture medium.
Serum fractionation
To estimate the molecular weight of proteins that had a positive
effect on the tubular cells the serum was fractionated using a
Superdex 200 gel filtration column (Pharmacia). Fibronectin
depleted serum (50 mg in 1 ml) was added to the column and
eluted off using a 0.15 M NaCl/0.05 M Na2HPO4 pH 7.2 buffer.
Four molecular weight fractions were collected: (A) > 440 kDa,
(B) 440 to 100 kDa, (C) 100 to 40 kDa and (D) <40 kD. Fraction
D thus contained proteins that were likely to be filtered by a
normal glomerulus. Fraction C contained proteins which would be
filtered in selective proteinuria, Fraction B proteins are only likely
to be filtered in nonselective proteinuria, Fraction A proteins are
so large as to be only minimally filtered even in severe glomerular
damage [171. The greatest concentration of proteins occurred in
fraction C, which contained the albumin, and this was added to
the cell cultures at a concentration of 1.0 mg/mi. The protein
concentrations of the other fractions were adjusted to be in the
same ratio to fraction C as they were in whole serum (A, 0.075
0.009 mg/mi; B, 0.457 0.030 mg/mI; D, 0.007 0.005 mg/mI).
Role of cytokines in the responses to serum
Platelet derived growth factor (PDGF) and transforming
growth factor p (TGFP) are cytokines which are known to play an
important part in many fibrotic reactions [18, 19] and are present
in normal serum. To determine whether either of these may be
contributing to the response to serum the concentrations of these
cytokines were measured in the serum fractions by commercially
available ELISA. To examine whether the effects of serum on
fibronectin production could be the result of increased production
of PDGF or TGFI3 by the HTC, which then act autocrinally to
stimulate fibronectin production, TGFI31 and PDGF-AB were
also assayed in the HTC conditioned culture medium.
Further investigation of the possible role of PDGF was inves-
tigated by determining the effects of the addition of anti-PDGF
neutralizing antibodies. HTC were grown to confluence on colla-
gen I coated permeable membrane supports in 12 well plates. On
reaching confluence the medium was changed to serum free
medium in a physiological concentration of glucose as previously
described. After 24 hours the following experimental conditions
were applied: (a) control, (b) addition of 1.0 mg/mI of serum
proteins to the apical medium, (c) anti-PDGF (5.0 ng/ml) in the
apical medium, (d) 1.0 mg/mi of serum + anti-PDGF (5.0 tg/ml)
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in the apical medium, (d) anti-PDGF (5.0 jxg/ml) in the basolat-
eral medium, (e) 1.0 mg/mi of serum in the apical medium +
anti-PDGF (5.0 .tg/ml) in the basolateral medium, (f) recombi-
nant PDGF-AB (1.0 ng/ml) in the apical medium and (g) recom-
binant PDGF-AB (1 nglml) in the basolateral medium. After 48
hours in culture the medium was removed and stored for fibronec-
tin assay.
Fibronectin assay
Fibronectin was measured in the apical and basolateral media
and in the cell protein solution using a sandwich ELISA. The
plates were coated with a rabbit polyclonal anti human fibronectin
antibody (1:1000 in coating buffer). Appropriately diluted samples
were incubated overnight. A mouse monoclonal anti human
fibronectin (1:500) was added for two hours and this was followed
by horseradish peroxidase conjugated anti-mouse immunoglobu-
lin (1:1000) for two hours. HRP was detected using o-phenylene-
diamine and the steep part of the sigmoid standard curve was
between 100 and 1000 ng/ml, which were used as the limits of
detectability of the assay. The coefficient of variation at the
midpoint of this range was 4.9%.
Lactate dehydrogenase assay
Following exposure of cells to serum protein fractions for 48
hours, lactate dehydrogenase was assayed in the apical and
basolateral media. Phosphate buffered saline containing 1% Tri-
ton X-100 was added to the cells which were scraped from the
supports. The cell suspension was then sonnicated to ensure
complete disruption of the cells. Total cellular LDH was mea-
sured in the cell lysates. LDH was assayed using a commercially
available (Sigma UK) enzyme kinetic method that measures the
rate of oxidation of nicotine adenine dinucleotide by a change in
optical density [201.
Statistics
Results are expressed as mean SCM. Statistics were performed
using Student's t-tests comparing conditions with the appropriate
control. P < 0.05 was taken as significant.
Results
Cell characterization
The morphology of the cells was epithelial with dome forma-
tion. Electron microscopy of the cells on the permeable supports
showed that they expressed microvilli on their apical surface
indicating an appropriate polarity. The cells stained positively for
epithelial membrane antigen and cytokeratin but negatively
for factor VIII related antigen. The cells stained positively for
nonspecific esterase, which distinguishes them from glomerular
epithelial cells [12]. Production of cAMP on exposure to parathy-
roid hormone increased by 12.27 1.55-fold (P < 0.001) com-
pared to control and on exposure to vasopressin by the lesser
amount of 3.87 0.76 fold (P < 0.001). These studies would
indicate that the cells are predominantly of proximal tubular
origin.
Permeability studies
To ensure that monolayers remained impermeable to proteins
during the experiments the monolayer permeability was measured
to '251-human albumin. In controls the leak of albumin from
Fig. 1. Production of fibronectin on apical exposure to semm proteins after
24 hours (A) and 48 hours (B). Dialyzed total serum proteins were added,
in the concentrations shown, to the medium bathing the apical side of
HTC. The equivalent volume of phosphate buffered saline was added to
the controls. Fibronectin was measured in the (Eli) apical and ()
basolateral media. Experiments were performed on 5 kidney preparations
and with 11 different sera, each performed in triplicate. *P < 0.001
compared with control.
apical to basolateral medium was only 0.44 0.04% at 24 hours
and 0.92 0.11% at 48 hours. On the addition of serum there was
no significant change in permeability at 24 hours (0.55 0.06%)
though by 48 hours the leak was 1.56 0.27%, which was higher
than the controls. Albumin precipitated by trichloroacetic acid
accounted for 54 5% of basolateral counts at 24 hours and 60
4% of basolateral counts at 48 hours with no difference in the
presence of apical serum. The monolayer therefore remained
tight under all experimental conditions with only very small
amounts of intact albumin being able to cross from the apical to
the basolateral medium.
Production of fibronectin by HTC
Human tubular cells in culture produce the matrix protein
fibronectin. Figure 1 shows that unstimulated cells in serum free
Fi
br
on
ec
tin
, p
g/
m
g c
e
ll p
ro
te
in
 
-
 
N
) 
C.
) 
0 
0 
0 
0 
I 
I 
I 
_
_
_
_
H
 
(D
- _
_
_
_
_
_
_
_
_
_
H
 
_
_
_
_
_
_
_
_
H
 
_
_
_
_
 
H
 
_
_
_
_
_
_
H
 
Burton et al: Fibronectin production by HTC 763
Table 1. Ratio of basolateral to apical secretion of fibronectin by HTC
in the presence or absence of serum proteins at 24 and 48 hours
Apical serum 24 hours 48 hours
Control 4.3 1.1 2.9 0.2
1.0 mg/mI 2.8 0.5 3.0 0.5
medium secreted fibronectin into both the apical and basolateral
media. This was detectable at 24 hours with further production up
to 48 hours. Basolateral secretion of fibronectin exceeded apical
secretion by 4.3 1.1-fold (P < 0.001) at 24 hours and by 2.9
0.2-fold (P < 0.001) at 48 hours (Table 1).
The effect of apical exposure to serum is shown in Figure 1.
Apical exposure to 0.1 mg/ml of normal serum did not alter
basolateral secretion of fibronectin. However, a small increase in
apical secretion of fibronectin was observed at 24 hours in the
presence of 0.1 mg/mI of apical serum, though this was not seen at
48 hours. Serum proteins at a concentration of 1.0 mg/mI resulted
in a significant increase in fibronectin secretion into both the
apical and basolateral media at 24 hours (3.49 1.75, P < 0.002,
fold increase apically, 2.62 0.23, P < 0.001, fold increase
basolaterally) and 48 hours (2.40 0.14, P < 0.001 fold increase
apically, 2.40 0.16, P < 0.001 fold increase basolaterally).
Basolateral secretion of fibronectin predominated over apical
secretion under all the conditions tested as shown in Table 1.
There was no significant difference in degree of polarity at either
time point or on exposure to serum proteins.
Cell associated fibronectin in the control wells was 4.87 0.44
jig/mg cell protein and on exposure to 1.0 mg/mI apical serum
proteins this was not significantly altered at 5.31 0.49 jig/mg cell
protein.
Heat inactivated serum
Since complement is known to affect cells in culture the serum
was heat inactivated and its ability to induce fibronectin produc-
tion tested. In parallel experiments heat inactivated serum in-
creased basolateral fibronectin production after 48 hours by
1.66 0.13-fold over controls compared to an increase of 1.88
0.14-fold with untreated serum. Heat inactivation did not, there-
fore, significantly alter the effect of serum on the production of
fibronectin.
Fractionation of the serum by molecular weight
To further characterize the response the serum was fraction-
ated by gel filtration into four molecular weight fractions. The
effect of the fractions on basolateral fibronectin secretion after 48
hours is shown in Figure 2. The increase in basolateral fibronectin
release caused by serum was entirely explained by fraction C. No
increase in fibronectin production was observed on incubation
with fractions A, B, or D. Qualitatively similar results were
obtained at 24 hours.
Since the cytokines PDGF-AB and TGFf3 are important cyto-
kines in fibrosing responses the possibility that they were involved
in the responses to serum, in these experiments was investigated.
1.0 mg/mI of serum added to the culture medium contained
0.320 0.25 ng/ml of PDGF-AB and 0.519 0.59 ng/ml of
TGFI31. PDGF-AB was just detectable in medium containing
fraction C (0.010 0.002 ng/ml) but was present in much higher
concentration in fraction D (0.16 0.01 ng/ml), a fraction that
Fig. 2. Effect of sensm fractions on basolateral production of fibronectin
after 48 hours. Serum fractions were obtained by gel filtration. The ability
of the fractions, when added to the apical medium, to stimulate basolat-
eral fibronectin production was compared to that of whole serum. A, B, C
and D are the serum fractions described in the text. S is whole serum (1.0
mg/mi). Results are from three kidney preparations and five serum
samples, each performed in triplicate. *P < 0.001 compared to control.
had no effect on fibronectin production. TGF!31 was undetectable
in medium containing fraction C and occured predominantly in
the inactive high molecular weight fractions A (0.34 0.07 ng/ml)
and B (0.093 0.008 ng/ml) presumably because it is bound to
carrier proteins. The effects observed in these experiments could
not therefore be explained by the presence of PDGF or TGFf31 in
the serum.
Production of TGFI3 and PDGF by HTC exposed to serum
TGF/31 was not detectable in basolateral HTC conditioned
medium under control conditions or on stimulation of the cells
with serum, the lower limit of detection of the assay being 30
pg/ml. The concentration of TGFI31 which was detectable in the
apical conditioned medium in the presence of serum was all
explainable by the amount of TGF/31 contained within the added
serum. PDGF-AB was detectable in the conditioned medium of
unstimulated HTC and as shown in Figure 3 addition of 1.0 mg/mI
of serum to the apical medium resulted in increased secretion of
PDGF-AB by HTC into both the apical and basolateral medium.
To investigate whether or not PDGF was the stimulator of
fibronectin production by serum, HTC were incubated with serum
together with neutralizing antibody to human PDGF and also with
exogenously added recombinant PDGF-AB. An excess of neutral-
izing antibody was used (5.0 j.tg/ml neutralizes 50% of the activity
of 10 ng/ml). The concentration of recombinant PDGF used was
1.0 ng/ml (compared to 0.32 0.02 ng/ml added with serum). The
results in Figure 4 show that neutralizing antibody to PDGF, if
added to either the apical or basolateral medium, did not signif-
icantly change the increased fibronectin secretion in response to
apical serum. Recombinant PDGF-AB did not increase fibronec-
tin production when added to the apical or basolateral medium.
Therefore, PDGF is not the cause of increased fibronectin
secretion by HTC on exposure to serum, although PDGF secre-
tion is itself increased by exposure to serum.
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Fig. 3. Production of platelet-derived growth factor by HTC and the effect of
apical exposure to serum. HTC were exposed to serum (1.0 mg/mi) in the
apical medium. After 48 hours the apical (LI) and basolateral () media
were sampled and PDGF assayed by ELISA. The results are from 4 kidney
preparations ad 7 serum samples, each performed in triplicate. P < 0.05;
< 0.05.
Fig. 4. Effect of anti-PDGF neutralizing antibody on the stimulation of
fibronectin secretion by serum at 48 hours. (a) Control, (b) 1.0 mg/mi apical
serum, (c) 5.0 rg/ml apical anti-PDGF antibody, (d) apical serum + 5.0
pJml anti-PDGF antibody, (e) 5.0 jrg/ml basolateral anti-PDGF antibody,
(f) apical serum + 5.0 jsg/ml basolateral anti-PDGF, (g) 1.0 nglml apical
PDGF-AB, (h) 1.0 ng/ml basolateral PDGF. These conditions were
applied to the HTC cultures for 48 hours, and the media were then
sampled and assayed for fibronectin. The results are from two kidney
preparations and four serum samples. Therc was no significant difference
heteen b, d and f, indicating that anti-PDGF does not alter the response
to serum. There was no significant difference between a, e, and e,
indicating that anti-PDGF did not have an independent effect on fibronec-
tin production by HTC. There was no significant difference between a, g
and h, indicating that exogcnously added PDGF had no effect on
fihroncctin secretion by HTC.
Effect of human albumin and transfrrrin
Two major components of fraction C are albumin (molecular
weight 67 kDa) and trarisferrin (molecular weight 76 kDa).
Therefore the effect of adding human albumin and transferrin
Fig. 5. Production of fibroneclin in response to apical human albumin and
human transferrin at 48 hours. Symbols are: (El) apical secretion; ()
basolateral secretion. Human albumin (ALB) was added to the apical
medium at a concentration of 1.0 mg/mI and transferrin (TF) was added
at a concentration of 0.05 mg/mI, which is the concentration in 1.0 mg/mI
of serum. Albumin results are from four kidney preparations and trans-
ferrin from 2 preparations, each in triplicate. *p < 0.005, **p < 0.001
compared to control.
alone to the culture was studied. Albumin (1.0 mg/mI) and
transferrin (50 xg/ml, the concentration present in 1.0 mg/mI of
serum) were added to the apical medium. The results are shown
in Figure 5. Albumin produces a small but significant increase in
apical fibronectin secretion at 48 hours. However, this effect was
insufficient to entirely explain the increase in apical fibronectin
brought about by serum. There was no increase in basolateral
fibronectin secretion on exposure to albumin. At neither time
point was the effect due to albumin sufficient to entirely explain
the response to serum either apically or basolaterally. Transferrin
at this concentration had no effect on the production of fibronec-
tin.
Cytotoxicily of serum proteins
It could be argued that the observed effects of serum proteins
on the cells in culture are due to an improvement in the cell
culture conditions rather than to a noxious insult. To investigate
this possibility the release of lactate dehydrogenase into the
culture medium was used as a measure of cytotoxicity [20]. There
was no polarity of release of LDH between the apical and
basolateral media. No differences were detectable in the total
cellular LDH under the various experimental conditions (4.31
0.24 lU/mg cell protein in controls, 4.69 0.22 lU/mg cell protein
on apical exposure to serum). LDH release into the culture media
as a proportion of total cell LDH in each well is shown in Figure
6. Far from indicating improved culture conditions, in the pres-
ence of serum, LDH activity was highest in the medium from cells
exposed to total serum and those exposed to fraction C indicating
that increased fibronectin secretion accompanies a cytotoxic effect
of serum. Apical addition of albumin and transferrin did not alter
the release of LDH.
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Fig. 6. Effect of apical serum proteins on the release of lactate dehydroge-
nase into the culture medium. The ability of serum fractions, when added
to the apical medium, to cause release of LDH into the culture medium
was compared to that of whole serum after 48 hours. A, B, C and D
represent the serum fractions as described in the text. S represents whole
serum (1.0 mg/ml). The results are from three kidney preparations and 5
serum samples each in triplicate. < 0.01, < 0.001 compared to
control.
Discussion
Over 20 years ago it was shown that pathological changes in the
tubulointerstitium were a better marker for the degree of renal
damage than glomerular changes [4, 5]. However, it is still not
known why the tubulointerstitium is damaged in primary glomer-
ular disease. The interstitial changes described in both human and
experimental renal disease are tubular atrophy, expansion of the
interstitium by matrix proteins including collagen types I and III
and fibronectin [2, 21], and an influx into the interstitium of
chronic inflammatory cells [2, 3]. Evidence suggesting a role for
proteinuria in progression of renal failure comes from both
human disease and animal models. A correlation between the
degree of proteinuria and the subsequent rate of progression of
renal failure has been described in many different human renal
diseases [7—10]. The two animal models that have been investi-
gated in most detail are the puromycin aminonucleoside nephro-
sis model [22] and protein overload model [23] in the rat. In both
models there is development of heavy proteinuria with initially
minimal change to the glomerular architecture on light micros-
copy [24]. However, there is a florid response within the intersti-
tium with an influx of chronic inflammatory cells, most of which
are macrophages and also the accumulation of matrix proteins
[25]. In both models the interstitial influx of cells is closely related
in time to the development of proteinuria.
In animal models treatments that are known to reduce the rate
of progression also decrease the amount of proteinuria. In the
remnant kidney model of renal failure in the rat low protein diets
[26], soya diets [27] and angiotensin converting enzyme inhibitors
[28] have all been used to slow the rate of progression and each of
these interventions results in decreased proteinuria. This has led
to the hypothesis that proteinuria, through effects on the tubular
cells, may in part be responsible for initiating the chronic inflam-
matory and scarring process in the interstitium.
Direct evidence that proteins present in the urine in glomerular
disease may be responsible for stimulating a proinflammatory
response in tubular cells comes from work by Kees-Folts Ct al [29,
30], who showed that in the protein overload model, the urine
contains chemoattractant activity for monocytes and that this
chemoattractant is produced by rat proximal tubular cells in
short-term culture when they are exposed to bovine serum
albumin carrying fatty acids.
Fibronectin is a matrix protein that is known to be present in
the interstitium of the scarred kidney [21]. Its site of origin has
not, however, been clearly defined. Two possible cells may secrete
fibronectin one is the interstitial fibroblast which is known to be
present in increased numbers in scarred kidneys [2, 21]. The other
is the tubular cells themselves that have been shown to produce
collagen type I [11] and recently shown to express mRNA for
fibronectin [31] in culture. The results presented here confirm that
human tubular cells are able to produce fibronectin protein and
may therefore contribute to its deposition in renal disease.
Production of fibronectin by the cells grown on membrane
supports is polarized with the greater amount of fibronectin being
released into the basolateral medium. This polarity is consistent
with the cells contributing fibronectin to their basement mem-
brane and to the extracellular matrix in interstitial scarring.
Damage to the glomerular barrier as a result of a variety of
glomerular diseases results in the leak of medium and high
molecular weight proteins into the fluid bathing the apical surface
of the tubular cells, which under normal circumstances are only
exposed to low molecular weight proteins. The current experi-
ments demonstrate that exposure of the apical surface of human
cortical epithelial cells to serum proteins (1.0 mg/mI) results in an
increase in production of fibronectin.
Micropuncture studies have shown in the nephrotic rat a
tubular protein concentration of 0.07 mg/ml [32]. On addition of
0.1 mg/ml of serum in these experiments there was an increase in
apical secretion but not basolateral secretion. Thus concentrations
of serum proteins in the range seen by proximal tubules in
proteinuric states have a demonstrable biological effect though
higher concentrations (1.0 mg/ml) are required to demonstrate a
basolateral increase in fibronectin production. Other authors have
used higher concentrations than 1.0 mglml of individual proteins
to demonstrate effects on cells in culture [33, 34]. The justification
for these apparently high concentrations is that in order to mimic
in vivo effects occurring over many months or years in short-term
cell culture systems it may be necessary to use a greater stimulus.
Since the normal turnover of the extracellular matrix requires a
balance between matrix production and degradation a relatively
small increase in production of matrix over a prolonged period
could upset the balance in favor of matrix deposition and result in
scarring.
Fractionation of the serum demonstrated that the stimulus to
fibronectin production was located in a fraction of molecular
weight 40 to 100 kDa. Hence it would be expected that the
responsible agent would not normally he filtered by the glomer-
ulus but would be filtered in glomerular disease. The molecular
weight of less than 100 kDa makes it likely that the protein is
filtered in selective proteinuria such as occurs in minimal change
nephropathy although it should be noted that the electrical charge
of proteins also influences their glomerular filtration. Minimal
change is not associated with interstitial disease, but there is an
increase in urinary lysozyme and n-aeetyl-f3-glucosaminidase in-
dicating that tubular injury does occur [35, 36], and it may be that
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the rapid resolution of proteinuria on treatment with steroids may
not allow sufficient time for interstitial scarring to develop. It is
also possible that the multifactorial process of interstitial scarring
requires additional factors to produce permanent interstitial
changes that are not present in minimal change disease.
Serum contains cytokines and growth factors that may promote
matrix production. Most of these are of low molecular weight and
would be expected to be fractionated into fraction D, which had
no effect on fibronectin production by the cells. It was confirmed
that the cytokine platelet-derived growth factor that is known to
be involved in fibrogenic responses and has been shown to
stimulate matrix production in some cell systems [18] was almost
exclusively found in fraction D. Platelet-derived growth factor was
also secreted by HTC under control conditions and exposure to
serum proteins in the apical medium resulted in increased pro-
duction of PDGF raising the possibility of autocrine stimulation of
fibronectin secretion by PDGF. However anti-PDGF neutralizing
antibodies did not reduce fibronectin secretion and exogenously
added recombinant PDGF-AB did not stimulate fibronectin se-
cretion ruling out an autocrine effect. Transforming growth factor
beta has in recent years been shown to be of prime importance in
many scarring responses and stimulates matrix production in
many cell types [19], however, TGFI3 was for the most part found
in the nonstimulatory fraction A where it is presumably bound
and inactive. Neither was TGFf3 produced in measurable amounts
by HTC, and thus could not be responsible for the fibronectin
production in these experiments.
Although the effect on fibronectin production was found in a
serum fraction composed predominantly of albumin and trans-
ferrin the addition of these proteins alone to the culture did not
mimic the effect of serum. After 48 hours human albumin alone
did not increase basolateral fibronectiri secretion, although there
was a small increase apically. This apical increase achieved with
albumin was always less than that observed with serum. There-
fore, either the effect of serum was due to another protein of
similar molecular weight to albumin active at low concentrations.
Alternatively, it could be due to a molecule carried by albumin
that is removed in commercial manufacture.
Since serum is a requirement for the growth of many cells in
culture, it would be possible that increased production of fi-
bronectin could merely indicate improved culture conditions in
the presence of human serum proteins. For this reason the
polarized model was developed and the cells exposed only api-
cally. Tubular cells would not he exposed to proteins on their
apical surface under normal conditions in vivo. To rule out a
beneficial effect of the proteins on the HTC the release of lactate
dehydrogenase into the culture medium was investigated. LDH is
not normally secreted and its release into the medium is a good
measure of cytotoxicity [20]. As shown in Figure 6, the LDH
release was increased by exposure of the cells to total serum and
to fraction C, whereas addition of albumin and transferrin did not
have this effect. Therefore, the circumstances in which there was
increased fibronectin secretion were associated with increased
cytotoxicity. Total cellular LDH was not altered by exposure to
apical serum which would argue against a generalized increase in
metabolic activity of the cells.
These experiments have demonstrated the ability of human
tubular cells to contribute to the scarring process in the intersti-
tium of the kidney by production of fibronectin. Basolateral
fibronectin production by the cells was increased by apical expo-
sure to serum proteins of a molecular weight to which the tubular
cells would be exposed in glomerular disease. The conditions in
which fibronectin secretion increased were associated with in-
creased cytotoxicity. These findings provide novel evidence that
tubular cell exposure to proteins, as may be found in proteinuric
states, could contribute to the pathophysiology of interstitial
scarring.
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